Volume 128, Issue 10 pp. 3365-3369
Zuschrift

A Telomerase-Specific Doxorubicin-Releasing Molecular Beacon for Cancer Theranostics

Yi Ma

Yi Ma

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
Zhaohui Wang

Zhaohui Wang

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
Min Zhang

Min Zhang

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
Zhihao Han

Zhihao Han

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
Dan Chen

Dan Chen

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
Qiuyun Zhu

Qiuyun Zhu

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
Weidong Gao

Weidong Gao

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
Prof. Dr. Zhiyu Qian

Corresponding Author

Prof. Dr. Zhiyu Qian

Department of Biomedical Engineering, School of Automation, Nanjing University of Aeronautics and Astronautics, 29 Yudao Street, Nanjing, 210016 China

Search for more papers by this author
Prof. Dr. Yueqing Gu

Corresponding Author

Prof. Dr. Yueqing Gu

State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Road, Nanjing, 210009 China

Search for more papers by this author
First published: 05 February 2016
Citations: 14

Abstract

A molecular beacon-based drug delivery system was designed for both detection of telomerase activity in living cells and telomerase-triggered drug release for precise cancer treatment. This system is composed of a gold nanoparticle core densely packed with FITC-labeled hairpin DNA sequences hybridized with telomerase primers. Molecules of the anticancer drug doxorubicin were intercalated into the stem region of the DNA sequence. The presence of telomerase will elongate the primers, leading to inner chain substitution followed by the release of the FITC fluorescence and the trapped doxorubicin. This molecular beacon could specifically distinguish tumor cells and normal cells based on telomerase activity, precisely release doxorubicin in response to telomerase activity in the tumor cells, and prevent toxicity to normal organs.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.